{"nct_id":"NCT03328078","title":"CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2017-12-28","start_date_type":"ACTUAL","primary_completion_date":"2026-08","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["CRIS"]}